Biote Q3 adjusted EBITDA USD 5.1 million
BTMD•Biote reported Q3 revenue of USD 43.3 million, below the USD 45.1 million estimate, and adjusted EBITDA of USD 5.1 million. It forecast full-year revenue of USD 175 million and adjusted EBITDA of USD 25 million.
1. Quarterly results and outlook
Biote reported Q3 gross margin of 67.7%, adjusted EBITDA margin of 11.7% and operating income of USD 2.5 million. Its full-year revenue outlook of USD 175 million compares with an IBES estimate of USD 180.7 million.
